Since, partial or complete deletions of one or both alleles of the PDE4D gene have been reported previously in prostate cancer [25–27] we utilized TCGA SNP array data of matching patient samples to assess the potential impact of deletions occurring in PDE4D on isoform expression. This evidence concerns the gene PDE4D and prostate carcinoma.